Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Coya Therapeutics, Inc. (COYA) vs Inovio Pharmaceuticals, Inc. (INO)

Coya Therapeutics, Inc. and Inovio Pharmaceuticals, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Inovio Pharmaceuticals, Inc. are of similar size ($126.9M and $121.5M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against −54.8%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 15 metrics below, Coya Therapeutics, Inc. leads on 9 and Inovio Pharmaceuticals, Inc. on 6.

Valuation

Metric COYA INO Biotechnology median
P/E n/m n/m 7.88
P/S 14.95 249.64 11.47
P/B 2.77 22.03 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 11.18 183.59 10.73
Earnings yield (20.94%) (77.12%) (28.84%)
Free cash flow yield (14.83%) (83.14%) (23.03%)

Profitability

Metric COYA INO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (409.87%) (57.72%)
Return on assets (53.66%) (114.64%) (49.22%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA INO Biotechnology median
Revenue growth (TTM) 108.35% (54.82%) 5.64%
EPS growth (last fiscal year) (29.59%) 54.18% —
Revenue growth, 5-year CAGR — (61.18%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA INO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 1.00 4.73
Net debt to EBITDA 2.08 0.70 0.96

Dividend

Metric COYA INO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric COYA INO Biotechnology median
Market cap 121.51m 126.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack